From: Radiolabeled nanomaterials for biomedical applications: radiopharmacy in the era of nanotechnology
223Ra labeled NPs | Particle size | Labeling method | Stage of research | References |
---|---|---|---|---|
Hydroxyapatite | 21.7 ± 6.9 nm (TEM) | Surface sorption, Intrinsic labeling | In vitro, radiochemical analysis | |
CaCO3 | 3–30 μm (light scattering) | Surface sorption | In vivo, rodents | Li et al. 2020) |
Fe3O4 | 4–26 nm (TEM) 284 nm (DLS) | Surface sorption | In vitro, radiochemical analysis | Mokhodoeva et al. 2016) |
Barium ferrite | 14–30 nm (TEM) | Intrinsic labeling | In vitro, cell lines | Gawęda et al. 2020) |
LaPO4 | 3–10 nm (TEM) | Surface sorption, Intrinsic labeling | In vitro, radiochemical analysis | Toro-González et al. 2020) |
TiO2 | 5.3 ± 1.7 nm (TEM) | Surface sorption, Intrinsic labeling | In vitro, radiochemical analysis | |
BaSO4 | 140 ± 50 nm (TEM/DLS) | Intrinsic labeling | In vitro, radiochemical analysis | Reissig et al. 2019) |
GdVO4 | length: 23–48 nm, width: 16–32 nm (TEM, pH dependent) | Intrinsic labeling | In vitro, radiochemical analysis | Toro-González et al. 2020) |
Nanozeolite | 30–800 nm (SEM) 226.1 ± 44.2 nm (DLS) | Intrinsic labeling | In vivo, rodents | |
Nanodiamonds Graphene oxide Nanotubes | 3–10 nm > 100 nm (HR-TEM) 30 nm | Surface sorption | In vitro radiochemical analysis | Kazakov et al. 2020)) |
Nanomicelles | 129.4 nm ± 0.3 (DLS) | Encapsulation | In vitro, cell lines | Yang et al. 2022) |